Mycoplasma pneumoniae are tiny bacteria typically known to cause lung infections. But now, a group of scientists have turned them into double agents. Genetically engineered Mycoplasma helped break down biofilms of another pathogenic microbe, Pseudomonas aeruginosa, in a mouse model of ventilator-associated pneumonia and on tube samples taken from human patients, the team reported January 19 in Nature Biotechnology. It is one of the first times that scientists have used live bacteria to treat a lung disease, and is the first therapeutic use of Mycoplasma.
“This approach is really powerful,” says Dave Hava, a microbiologist who wasn’t involved in the research, but who works at a company called Synlogic that develops live bacteria therapeutics for gut issues. “It offers the chance to target diseases and mechanisms that you can’t do with conventional therapies.”
Biological and chemical weapons have the potential to pose a national security threat to the U.S. that the country is not equipped to handle, a panel of lawmakers and a military leader told an audience at the Aspen Security Forum.
Welcome to Futureunity, where we explore the fascinating world of science, technology, and the universe! From the inner workings of the human body to the outer reaches of space, we delve into the latest and most interesting discoveries that are shaping our world. Whether you’re a science buff or just looking for some mind-blowing facts, we’ve got you covered. Join us as we uncover the mysteries of the world around us and discover new frontiers in the fields of science and technology. Get ready for a journey that’s both educational and entertaining!
Disclaimer Fair Use: 1. The videos have no negative impact on the original works. 2. The videos we make are used for educational purposes. 3. The videos are transformative in nature. 4. We use only the audio component and tiny pieces of video footage, only if it’s necessary. Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research. Fair use is a use permitted by copyright statutes that might otherwise be infringing.
Disclaimer: Our channel is based on facts, rumors & fiction.
Nearly 15,500 people in the U.S. over age 50 are estimated to have VEXAS syndrome.
A rare disorder called VEXAS syndrome has bemused the United States’ health services since 2020. The syndrome was a great mystery until the researchers’ work yielded results.
As stated by NYU Langone Health, with up to 50 percent of sufferers, mostly men, passing away within five years of diagnosis, this illness has a significant mortality rate.
BlackJack3D/iStock.
A new study led by the NYU Grossman School of Medicine has shown that about 13,200 men and another 2,300 women in the United States over age 50 are estimated to have VEXAS syndrome.
The technology can detect disorders up to six months earlier than a doctor.
Researchers are using motion capture artificial intelligence technology that brings characters to life in films like Avatar to track the onset of diseases which affect movement, according to a report by the BBC
Dr Valeria Ricotti, part of the team that is working on the new development, told BBC News that she was “completely blown away by the results”.
Film Spot/YouTube.
The new system uses artificial intelligence to analyze body movements and diagnose disorders twice as quickly as the best doctors.
Whether we realize it or not, cryptography is the fundamental building block on which our digital lives are based. Without sufficient cryptography and the inherent trust that it engenders, every aspect of the digital human condition we know and rely on today would never have come to fruition much less continue to evolve at its current staggering pace. The internet, digital signatures, critical infrastructure, financial systems and even the remote work that helped the world limp along during the recent global pandemic all rely on one critical assumption – that the current encryption employed today is unbreakable by even the most powerful computers in existence. But what if that assumption was not only challenged but realistically compromised?
This is exactly what happened when Peter Shor proposed his algorithm in 1995, dubbed Shor’s Algorithm. The key to unlocking the encryption on which today’s digital security relies is in finding the prime factors of large integers. While factoring is relatively simple with small integers that have only a few digits, factoring integers that have thousands of digits or more is another matter altogether. Shor proposed a polynomial-time quantum algorithm to solve this factoring problem. I’ll leave it to the more qualified mathematicians to explain the theory behind this algorithm but suffice it to say that when coupled with a quantum computer, Shor’s Algorithm drastically reduces the time it would take to factor these larger integers by multiple orders of magnitude.
Prior to Shor’s Algorithm, for example, the most powerful computer today would take millions of years to find the prime factors of a 2048-bit composite integer. Without Shor’s algorithm, even quantum computers would take such an inordinate amount of time to accomplish the task as to render it unusable by bad actors. With Shor’s Algorithm, this same factoring can potentially be accomplished in a matter of hours.
There’s an eerie similarity to the statements tech companies have made about their recent layoffs. Mainly, if the press releases are to be believed, the C-suite of every Big Tech company on Earth — well, with the notable exception of Apple, which has not announced layoffs — figured no one would ever go outside or spend money offline again after the pandemic and their various online businesses would stay just as big as they were during the heights of covid.
I do love a heavily lawyered statement that was clearly written by the public relations department! In fact, these are all so similar that they might as well have come from the same PR person… More.
All of these statements sound suspiciously similar.
More than one-third of UK health experts are not aware of Charles Bonnet syndrome — CBS — a condition which can cause vivid, and sometimes frightening, hallucinations.
A poll of 1,100 health experts — including GPs, doctors and optometrists — found 37 per cent were not aware of CBS.
The condition is not caused by mental health problems or dementia. It is purely due to a loss of sight — 60 per cent or more — which reduces or stops the regular messages from the eye to the brain.
In this video, Dr. Lee Hood traces the beginnings of systems biology and the founding of the Institute for Systems Biology to its role in the creation of systems (P4) medicine and ISB’s recent affiliation with Providence.
Dr. Lamberski leads a unified team of conservation scientists, researchers, wildlife nutritionists, and wildlife veterinarians, cultivating a strategic approach to conservation efforts. She is aligning San Diego Zoo Wildlife Alliance with other global conservation organizations and developing strategies that safeguard biodiversity so all life can thrive.
Dr. Lamberski joined the San Diego Zoo Safari Park in 2001 as senior veterinarian, following seven years as the senior veterinarian at Riverbanks Zoological Park and Botanical Garden in Columbia, South Carolina. She completed an internship at the University of Tennessee and Zoo Knoxville, followed by a zoological medicine residency at the University of California, Davis.
Dr. Lamberski has focused her career on the health and welfare of zoological species, as well as on the conservation impacts of disease on small or fragmented wildlife populations. She has participated in several field projects, most notably studying black-footed cats in southern. Africa, thick-billed parrots in northern Mexico, desert tortoises in the Southwestern United States, and working with partners at the Reteti Elephant Sanctuary in northern Kenya. She is inspired by the next generation of wildlife veterinarians and conservationists and has a special. interest in organizational leadership.
Dr. Lamberski is a Diplomate of the American College of Zoological Medicine (ACZM) and European College of Zoological Medicine (ECZM) in zoo health management (ZHM). She received her undergraduate degree in zoology and DVM from the University of Georgia.
Dr. Lamberski is a member and past president of the American Association of Zoo Veterinarians and a member of the American Veterinary Medical Association, American College of Zoological.
